Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Exposure to particulate matter worsens postpartum hair loss by affecting inflammation and cell death pathways.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Cosmetic dermatology is improving with new technologies but faces ethical and regulatory challenges.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Oral mucosa heals with minimal scarring, offering insights for scarless wound healing.

The skin's immune system helps it regenerate and fight infections.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.